Form 8-K - Current report:
SEC Accession No. 0001047469-98-034110
Filing Date
1998-09-09
Accepted
1998-09-09 00:00:00
Documents
6
Period of Report
1998-06-12
Items
Item 5: Other events
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 8-K 8-K 7409
2 EXHIBIT 10.1 EX-10.1 73601
3 EXHIBIT 10.2 EX-10.2 37572
4 EXHIBIT 10.3 EX-10.3 49126
5 EXHIBIT 10.4 EX-10.4 36382
6 EXHIBIT 10.5 EX-10.5 4745
  Complete submission text file 0001047469-98-034110.txt   210732
Mailing Address 9000 HARRY HINES BLVD DALLAS TX 75235
Business Address 9000 HARRY HINES BLVD STE 330 DALLAS TX 75235 2143532922
CYTOCLONAL PHARMACEUTICS INC /DE (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26078 | Film No.: 98706050
SIC: 2834 Pharmaceutical Preparations